Holen Sie sich die Stockscreener-App
7.01
3.31%
-0.24
Handel nachbörslich:
7.01
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RCEL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$7.25
Offen:
$7.26
24-Stunden-Volumen:
497.81K
Relative Volume:
2.13
Marktkapitalisierung:
$243.46M
Einnahmen:
$50.14M
Nettoeinkommen (Verlust:
$-35.38M
KGV:
-5.0071
EPS:
-1.4
Netto-Cashflow:
$-39.46M
1W Leistung:
-23.89%
1M Leistung:
-18.68%
6M Leistung:
-45.53%
1J Leistung:
-16.05%
1-Tages-Spanne:
$6.77
$7.4299
1-Wochen-Bereich:
$6.60
$9.845
52-Wochen-Spanne:
$6.60
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Firmenname
Avita Medical Inc
Sektor
Branche
Telefon
661-568-1317
Adresse
28159 AVENUE STANFORD, VALENCIA, CA
Vergleichen Sie RCEL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
7.01 | 243.46M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
129.05 | 231.50B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.95 | 154.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.53 | 144.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.11 | 105.58B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.50 | 43.95B | 5.54B | 4.18B | 623.10M | 7.00 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-24 | Eingeleitet | D. Boral Capital | Buy |
| 2024-04-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-06-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-03-02 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-27 | Eingeleitet | BofA Securities | Buy |
| 2020-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-03 | Eingeleitet | BTIG Research | Buy |
Alle ansehen
Avita Medical Inc Aktie (RCEL) Neueste Nachrichten
AVITA downgraded by Piper Sandler over sales outlook - MSN
AVITA Medical's Acute Wound Care Showcase 2025 Streams Live Today - The Manila Times
AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today - Stock Titan
AVITA Medical: Near Perfect Execution Needed To Navigate Through Balance Sheet Challenges - Seeking Alpha
Why AVITA, Botanix, Brainchip, and NAB shares are falling today - The Motley Fool Australia
Analysts Have Been Trimming Their AVITA Medical, Inc. (NASDAQ:RCEL) Price Target After Its Latest Report - Yahoo Finance
Contrasting GBS (NYSE:GBS) and AVITA Medical (NASDAQ:RCEL) - Defense World
Wells Fargo & Company MN Boosts Stock Position in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
AVITA Medical, Inc. (NASDAQ:RCEL) Q1 2025 Earnings Call Transcript - Insider Monkey
Cantor maintains Avita Medical stock Overweight, $19 target post-Q1 By Investing.com - Investing.com Canada
AVITA Medical outlines $3.5B US market opportunity with expanded product portfolio and 2025 revenue guidance - MSN
Avita Medical (RCEL) Target Price Adjusted by TD Cowen | RCEL St - GuruFocus
Avita Medical Shares Decline on 1Q Revenue Miss - MarketWatch
Barclays PLC Purchases 3,526 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita’s Road to Profitability Is in Sight - Morningstar
AVITA Medical (RCEL) Sees Revenue Surge with Product Launches - GuruFocus
AVITA Medical Inc (AVHHL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
AVITA Medical Inc (AVHHL) Q1 2025 Earnings Call Highlights: Stro - GuruFocus
Avita Medical Earnings: Fair Value Estimate Cut on Unlikely Vitiligo Reimbursement Support - Morningstar
AVITA Medical Inc (AVHHL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Shifts - GuruFocus
AVITA Medical Reports Strong Q1 2025 Growth - TipRanks
Avita Medical's Loss Narrows in Q1 as Revenue Grows; Shares Down 20% - marketscreener.com
AVITA Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
AVITA Medical (RCEL) Reports Significant Revenue Growth with New Product Launches | RCEL Stock News - GuruFocus
AVITA Medical Q1 2025 slides reveal growth strategy as stock tumbles on earnings miss - Investing.com Canada
AVITA Medical Reports First Quarter 2025 Financial Results - The Manila Times
AVITA Medical (RCEL) Projected to Post Earnings on Thursday - MarketBeat
(RCEL) Long Term Investment Analysis - news.stocktradersdaily.com
AVITA Medical, Inc. (NASDAQ:RCEL) Shares Bought by JPMorgan Chase & Co. - Defense World
Russell Investments Group Ltd. Acquires 2,324 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Geode Capital Management LLC Raises Stock Position in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025 - Stock Titan
Avita Uses Its Tech To Treat Wounds - Los Angeles Business Journal
AVITA Medical to Announce First Quarter 2025 Financial Results - The Manila Times
AVITA Medical to Announce First Quarter 2025 Financial Results | RCEL Stock News - GuruFocus
Leading Wound Care Company AVITA Medical Announces Q1 2025 Earnings Call Details - Stock Titan
The new medical device company to watch - Morningstar
Vanguard Group Inc. Has $18.22 Million Stock Holdings in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
AVITA Medical, Inc. Announces Chief Executive Officer Changes - marketscreener.com
D. Boral Capital Reiterates Buy Rating for AVITA Medical (NASDAQ:RCEL) - Defense World
AVITA Medical, Inc.'s (NASDAQ:RCEL) Profit Outlook - simplywall.st
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025 | RCEL Stock News - GuruFocus
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025 - The Manila Times
AVITA Medical (NASDAQ:RCEL) Receives "Buy" Rating from D. Boral Capital - MarketBeat
AVITA Medical (NASDAQ:RCEL) Earns “Buy” Rating from D. Boral Capital - Defense World
6 Analysts Assess AVITA Medical: What You Need To Know - Benzinga
AVITA Medical Announces US Commercial Launch Of Cohealyx - marketscreener.com
Avita Medical's Cohealyx Wound Treatment Makes Commercial Launch in US; Shares Down 4% - MarketScreener
AVITA Medical launches Cohealyx in the U.S. market By Investing.com - Investing.com South Africa
AVITA Medical Launches Wound Care Product Cohealyx in US - MarketScreener
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity - The Manila Times
Finanzdaten der Avita Medical Inc-Aktie (RCEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):